Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052). - Hiroshi Asano; Katsutoshi Oda; Kosuke Yoshihara; Yoichi M. Ito; Noriomi Matsumura; Muneaki Shimada; Hidemichi Watari; Takayuki Enomoto (Journal of Gynecologic Oncology, 2022)